Cord Blood
A Market Insight into the Progressing and Debatable Market of Stem Cell Research
Published in Blood Weekly, August 9th, 2007
This report analyzes the prevalent stem cell technologies and the therapeutic areas in which stem cells find their applications. The study provides a market insight into the ever progressing and debatable market of Stem Cell Research segmented by type, technology and therapeutic area. Stem Cells by Type are further classified into Adult Stem Cells, Embryonic Stem Cells, and Cord Blood Stem Cells. Stem Cell Research by Technology is segmented into Stem Cell Transplantation, Cell Based Genomics, Xenotransplantation, Cord Blood...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2007-08-09)
More Articles from Blood Weekly
- Cancer
Cancer risk does not increase for recipients of blood transfusions from donors with undiagnosed cancer - Sickle Cell Anemia
Red Cell Substitute Shows Promise as Treatment for Sickle Cell Disease - Artificial Organs
German and French CardioWest Artificial Heart Patients Enjoy a Better Quality of Life Than Americans - Cerus Corporation
Grifols S.A. and Cerus Corporation Agree to Commercialize the INTERCEPT Blood System in Spain and Portugal - Clinical and Laboratory Standards Institute (CLSI)
CLSI Publishes Guideline on Platelet Function Testing by Aggregometry - Cutaneous T-Cell Lymphoma
Journal of Clinical Oncology Publishes Data on ZOLINZA (vorinostat), Merck's Treatment for Advanced Cutaneous T-cell Lymphoma - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
